moksha8 Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:moksha8 Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013949
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ブラジル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Moksha8 Pharmaceuticals Inc (moksha8) is a drug company that offers therapeutic products. The company manufactures and commercializes products for the treatment of critical diseases. It provides vilazodone HCI for depressive disorder. moksha8’s other products include vilazodone HCL, mirtazapine, donepezil, risperidone, topiramate, olanzapine and quetiapine, among others. The company’s topiramate is used for migraine prevention and epilepsy; and olanzapine is used schizophrenia and bipolar disorder. Its products also find application in the areas of central nervous system, epilepsy, depressive disorder, cardiovascular, anti-infective products and pain management. The company operates through research laboratories, pharmaceutical and biotechnology companies. It has its presence in Mexico. moksha8 is headquartered in Sao Paulo, Brazil.

moksha8 Pharmaceuticals Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
moksha8 Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
moksha8 Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
moksha8 Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
moksha8 Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
moksha8 Pharmaceuticals Inc, Medical Devices Deals, 2011 to YTD 2017 9
moksha8 Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
moksha8 Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Laboratorios Biopas Enters into Distribution Agreement with moksha8 Pharma 11
Licensing Agreements 12
Bial Enters into Licensing Agreement with Moksha8 Pharma for Eslicarbazepine Acetate 12
Forest Labs Amends Licensing Agreement With moksha8 For Viibryd 13
Watson Pharma Enters Into Licensing Agreement With moksha8 Pharma For Five Generic Central Nervous System Products 14
Forest Labs Enters Into Licensing Agreement With moksha8 For Viibryd 15
Acquisition 16
Watson Pharma Sells Minority Stake In moksha8 Pharma For US$47 Million 16
moksha8 Pharmaceuticals Inc – Key Competitors 17
moksha8 Pharmaceuticals Inc – Key Employees 18
moksha8 Pharmaceuticals Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
moksha8 Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts 2
moksha8 Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
moksha8 Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
moksha8 Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
moksha8 Pharmaceuticals Inc, Deals By Therapy Area, 2011 to YTD 2017 8
moksha8 Pharmaceuticals Inc, Medical Devices Deals, 2011 to YTD 2017 9
moksha8 Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Laboratorios Biopas Enters into Distribution Agreement with moksha8 Pharma 11
Bial Enters into Licensing Agreement with Moksha8 Pharma for Eslicarbazepine Acetate 12
Forest Labs Amends Licensing Agreement With moksha8 For Viibryd 13
Watson Pharma Enters Into Licensing Agreement With moksha8 Pharma For Five Generic Central Nervous System Products 14
Forest Labs Enters Into Licensing Agreement With moksha8 For Viibryd 15
Watson Pharma Sells Minority Stake In moksha8 Pharma For US$47 Million 16
moksha8 Pharmaceuticals Inc, Key Competitors 17
moksha8 Pharmaceuticals Inc, Key Employees 18
moksha8 Pharmaceuticals Inc, Other Locations 19

★海外企業調査レポート[moksha8 Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Qsc AG (QSC):企業の財務・戦略的SWOT分析
    Summary Qsc AG (Qsc) is a telecommunication company that provides integrated telecommunication and managed services. The company offers services such as cloud and IT outsourcing, Internet of Things services, sap services and consulting, broadband and network services, and colocation services. Its cl …
  • AU Optronics Corp.:企業の戦略・SWOT・財務情報
    AU Optronics Corp. - Strategy, SWOT and Corporate Finance Report Summary AU Optronics Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Globus Spirits Limited:企業の戦略・SWOT・財務情報
    Globus Spirits Limited - Strategy, SWOT and Corporate Finance Report Summary Globus Spirits Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Everist Genomics Inc-医療機器分野:企業M&A・提携分析
    Summary Everist Genomics Inc (Everest Health), formerly Genetics Squared Inc is a developer of prognostics, medical diagnostic and therapeutic selection technologies. The company provides angiodefender cardiovascular disease diagnostic system, a non invasive device that is used for combining sensor …
  • AMP Solar Group Inc:電力:M&Aディール及び事業提携情報
    Summary AMP Solar Group Inc (AMP Solar Group) is an alternative energy company that offers solar and photovoltaic turnkey solutions. The company provides development of rooftop and ground based solar projects. It builds solar power projects in government and commercial sectors. AMP Solar Group opera …
  • Sanlam Limited:企業の戦略・SWOT・財務分析
    Sanlam Limited - Strategy, SWOT and Corporate Finance Report Summary Sanlam Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Myriad Genetics, Inc.:企業の戦略・SWOT・財務分析
    Myriad Genetics, Inc. - Strategy, SWOT and Corporate Finance Report Summary Myriad Genetics, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Phoenix Children’s Hospital-医療機器分野:企業M&A・提携分析
    Summary Phoenix Children's Hospital (PCH) is a healthcare center that provides medical services. The center’s services include anestesiology, dermatology, dermatology, child protection, bone marrow transplants, adolescent medicine, critical care, emergency medicine, developmental paediatrics and fet …
  • Claris Lifesciences Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Claris Lifesciences Ltd (Claris) is a manufacturer of generic drugs and pharmaceutical products. The company provides generic drugs that are directly injected into the human body, which is mainly used in the treatment of critical illnesses. It provides products are offered through various de …
  • Ctrip.Com International Ltd:企業の戦略・SWOT・財務分析
    Ctrip.Com International Ltd - Strategy, SWOT and Corporate Finance Report Summary Ctrip.Com International Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Imprimis Pharmaceuticals Inc (IMMY):製薬・医療:M&Aディール及び事業提携情報
    Summary Imprimis Pharmaceuticals Inc (Imprimis), formerly Transdel Pharmaceuticals Inc., focuses on the development and commercialization of proprietary drug formulations in the therapeutic areas of urology and ophthalmology. The company by utilizing its SSP Technology develops injectable Dropless T …
  • Power Corporation of Canada:企業の戦略・SWOT・財務情報
    Power Corporation of Canada - Strategy, SWOT and Corporate Finance Report Summary Power Corporation of Canada - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Nomura Holdings, Inc.:企業の戦略・SWOT・財務情報
    Nomura Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Nomura Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Breg Inc:医療機器:M&Aディール及び事業提携情報
    Summary Breg Inc (Breg) is a medical device company that manufactures and distributes sports medicine and rehabilitation products. The company offers products such as knee braces, cold therapy, dvt prophylaxis, hip bracing, shoulder bracing, fracture bracing, elbow wrist bracing, spine bracing, foot …
  • Actuate Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Actuate Therapeutics Inc (Actuate Therapeutics) is a biopharmaceutical company that offers development of novel compounds for the treatment of cancer and inflammatory diseases. The company’s lead compound 9-ING-41 is under evaluation for anti-tumor activity in various vivo models. It also de …
  • Bioprognos SL:企業の製品パイプライン分析2018
    Summary Bioprognos SL (Bioprognos) is a cancer diagnostics company that develops non-invasive and accurate diagnostics solutions. The company’s pipeline products include OncoBREAST Dx, OncoLUNG Dx, OncoOVARIAN Dx, OncoPROSTATE Dx, OncoCUP Dx, OncoLIVER Dx, OncoNECK Dx, OncoBLADDER Dx, and OncoCOLON …
  • Wilson Vale:企業の戦略・SWOT・財務情報
    Wilson Vale - Strategy, SWOT and Corporate Finance Report Summary Wilson Vale - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Calpine Corporation (CPN):電力:M&Aディール及び事業提携情報
    Summary Calpine Corporation (Calpine) is an electric and natural gas utility. The company produces electricity and thermal energy from natural gas, geothermal, and solar sources. It uses natural gas-fired combustion and renewable geothermal conventional steam turbine technologies to generate energy. …
  • KUKA AG (KU2):企業の財務・戦略的SWOT分析
    KUKA AG (KU2) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Bank of Scotland Plc:企業のM&A・事業提携・投資動向
    Bank of Scotland Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bank of Scotland Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆